JP Morgan Chase’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
JP Morgan Chase's RCUS Position: Q3 2026 in Review
JP Morgan Chase increased its Arcus Biosciences (RCUS) stake by 83% in Q3 2026, buying an estimated $9.8M and bringing the position to 765,041 shares worth $19.7M. The position accounts for ﹤0.01% of the portfolio, ranked #2233.
JP Morgan Chase first reported a position in RCUS in Q1 2018 and has held it in 35 quarters since. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- JP Morgan Chase held 765,041 shares of Arcus Biosciences worth $19.7M as of Q3 2026.
- JP Morgan Chase bought 346,798 Arcus Biosciences shares in Q3 2026, an estimated $9.8M.
- Arcus Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q3 2026, its #2233 holding.
- JP Morgan Chase first reported a position in Arcus Biosciences in Q1 2018 and has held it in 35 quarters since.
- 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on JP Morgan Chase's 13F filing for Q3 2026, filed 12 Nov 2026.